Carl Dean Stevens - Ischemic Optic Neuropathy Stem Cell Patient

Carl received adult stem cell transplants in China in 2007 for the treatment of Ischemic Optic Neuropathy. The donated umbilical cord blood stem cells were transplanted to Carl to help stimulate redevelopment of his optic nerve. Three years along, Carl still maintains the light perception he got back during the treatment. Adult stem cell treatments available today are not cures for Ischemic Optic Neuropathy. Carl's visual improvement, while significant in improving his quality of life, does not amount to a full recovery. Stem cell therapies offering quality of life improvements to debilitating conditions are available and accessible today.

Improvement statistics

Based on follow-up reports from 22 patients across 54 forms, here is the percentage who self-reported any improvement after treatment.

90%
Interaction with others
reported improvement · N=10
81%
Trunk muscle strength
reported improvement · N=16
80%
Balance
reported improvement · N=20
80%
Overall strength
reported improvement · N=15
80%
Cooperation with others
reported improvement · N=10
79%
Energy
reported improvement · N=14
78%
Movement in general
reported improvement · N=18
77%
Limb muscle strength
reported improvement · N=17
75%
Trunk control
reported improvement · N=16
75%
Range of movement
reported improvement · N=16

About this data

Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.

Internationally accredited

Held to global laboratory and biologics standards.